Select Page

MyPeBS
is an international

EU-funded clinical study
that evaluates a new breast cancer screening strategy

9
4
5

Women
included in
the study so far

Due to the COVID-19 outbreak,
enrollment in the MyPeBS study is suspended until further notice.

What is MyPeBS ?

MyPeBS (My Personal Breast Screening) is a major ambitious European initiative. This unique international clinical study compares a personalised risk-based screening strategy (based on the individual women’s risk of developing breast cancer) to standard screening among 85,000 women aged 40 to 70 in 5 countries: Belgium, France, Israel, Italy, and United Kingdom.

MyPeBS (My Personal Breast Screening) is a major ambitious European initiative. This unique international clinical study compares a personalised risk-based screening strategy (based on the individual women’s risk of developing breast cancer) to standard screening among 85,000 women aged 40 to 70 in 5 countries: Belgium, France, Israel, Italy, and United Kingdom.

Animation video presenting the MyPeBS study

News

Envision network consensus statement

Envision network consensus statement

The MyPeBS consortium is proud to announce the publication of the Envision network consensus statement on personalized early detection and prevention of breast cancer. MyPeBS is one of the 5 founders of the ENVISION initiative Summary of the paper: “The European...

read more

Partners

Members of the MyPeBS Consortium
Associated partners
Members of the MyPeBS Consortium
Associated partners
Members of the MyPeBS Consortium
Members of the MyPeBS Consortium
Members of the MyPeBS Consortium
Members of the MyPeBS Consortium
Members of the MyPeBS Consortium

The MyPeBS study is supported by the French Health Insurance and the French National Cancer Institute (INCa), and has been approved by the Cancer Screening Strategic Committee chaired by the French General Director of Health.